Comparative assessment of the transduction efficiency and safety associated with the delivery of AAV9-GFP vector via lumbar puncture to cynomolgus macaques with and without anti-AAV9 pre-existing antibodies.
第一作者:
Ghiabe H,Guibinga
第一单位:
Novartis Gene Therapies, San Diego, CA, USA.;Biologics Research Center (BRC), Novartis Biomedical Research, San Diego, CA, USA.
作者:
DOI
10.1016/j.omtm.2024.101371
PMID
39717225
发布时间
2025-01-04
- 浏览0

Molecular therapy. Methods & clinical development
2024年32卷4期
101371页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文